1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Autism-Pipeline Insights, 2014

Autism-Pipeline Insights, 2014

  • August 2014
  • -
  • Delve Insight

SUMMARY
DelveInsight’s,“ Autism-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Autism. This report provides information on the therapeutic development based on the Autism dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.

Scope
- The report provides a snapshot of the global therapeutic landscape of Autism
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Autism pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Autism and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


Reasons to buy
- Complete Pipeline intelligence and complete understanding over therapeutics development for Autism
- Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
- Devise corrective measures for pipeline projects by understanding Autism pipeline depth and focus of Indication therapeutics
- Developing strategic initiatives to support your drug development activities.
- Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
- Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
- Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

Table Of Contents

Autism-Pipeline Insights, 2014
Table of Contents
- Autism Overview
- Autism Pipeline Therapeutics
- Autism Therapeutics under Development by Companies
- Autism Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Autism Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Autism Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Autism Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Autism - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Autism - Discontinued Products
- Autism - Dormant Products
- Companies Involved in Therapeutics Development for Autism
- Appendix
- Methodology
- Contact Us
- Disclaimer

List of Tables

- Number of Products under Development for Autism, 2014
- Number of Products under Development by Companies
- Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
- Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
- Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
- Drug Candidates Profiles
- Autism Assessment by Monotherapy Products
- Autism Assessment by Combination Products
- Autism Assessment by Route of Administration
- Autism Assessment by Stage and Route of Administration
- Autism Assessment by Molecule Type
- Autism Assessment by Stage and Molecule Type
- Autism Therapeutics - Discontinued Products
- Autism Therapeutics - Dormant Products
- Products under Development by Companies, 2014

List of Figures

- Number of Products under Development for Autism, 2014
- Late Clinical Stage Products (Filed and Phase III), 2014
- Mid Clinical Stage Products (Phase II), 2014
- Early Clinical Stage Products (Phase I and IND Filed), 2014
- Discovery and Pre-Clinical Stage Products, 2014
- Autism Assessment by Monotherapy Products
- Autism Assessment by Combination Products
- Autism Assessment by Route of Administration
- Autism Assessment by Stage and Route of Administration
- Autism Assessment by Molecule Type
- Autism Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Neurovascular Devices/Interventional Neurology Market by Product, Pathology - Global Forecasts to 2021

Neurovascular Devices/Interventional Neurology Market by Product, Pathology - Global Forecasts to 2021

  • $ 5650
  • Industry report
  • March 2017
  • by MarketsandMarkets

The global neurovascular devices/interventional neurology market is estimated reach USD 2.62 million at a CAGR of 8.6% during 2016-2021. As of 2016, North America and Europe holds the largest share of ...

Aortic Aneurysm Repair Devices Global Market  – Forecast To 2023

Aortic Aneurysm Repair Devices Global Market – Forecast To 2023

  • $ 4950
  • Industry report
  • January 2017
  • by IQ4I Research & Consultancy Pvt. Ltd

An aneurysm develops due to the weakening of blood vessel which results in a balloon-like dilation. Aneurysms can occur in any artery, it happens most often in the abdominal aorta, an essential blood vessel ...

Patient Temperature Management Market By Product (Patient Warming Systems, Patient Cooling Systems), By Application (Surgery, Cardiology, Pediatrics, Neurology), By End Use (Operating Room, Neonatal ICU, ER, ICUs) And Segment Forecasts, 2014 - 2025

Patient Temperature Management Market By Product (Patient Warming Systems, Patient Cooling Systems), By Application (Surgery, Cardiology, Pediatrics, Neurology), By End Use (Operating Room, Neonatal ICU, ER, ICUs) And Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • January 2017
  • by Grand View Research

The global patient temperature management market is anticipated to reach a value of USD 4.5 billion by 2025, according to a new report by Grand View Research, Inc. Growing number of surgical procedures ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.